Protagonist Therapeutics
PTGX
#2853
Rank
โ‚ฌ4.86 B
Marketcap
77,83ย โ‚ฌ
Share price
1.06%
Change (1 day)
103.05%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2025 (TTM): โ‚ฌ0.19 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.17 Billion. In 2024 the company made a revenue of โ‚ฌ0.41 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ54.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.19 B-52.36%
2024 โ‚ฌ0.41 B669.17%
2023 โ‚ฌ54.27 M119.03%
2022 โ‚ฌ24.78 M2.58%
2021 โ‚ฌ24.15 M3.79%
2020 โ‚ฌ23.27 M11187.16%
2019 โ‚ฌ0.2 M-99.24%
2018 โ‚ฌ27.03 M61.67%
2017 โ‚ฌ16.72 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA